Evidence map›Paper›PMID 33215756›Full record

ArticleThe EMBO journal2021

Phosphoproteomics reveals novel modes of function and inter-relationships among PIKKs in response to genotoxic stress.

Sapir Schlam-Babayov, Ariel Bensimon, Michal Harel, Tamar Geiger, Ruedi Aebersold, Yael Ziv, Yosef Shiloh

Open access · bronzeAbstract read
In one paragraph

Article in The EMBO journal, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 48 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Profile of Yosef Shiloh.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  6. Article
  7. Making PI3K superfamily enzymes run faster.Advances in biological regulation · 2025
    Review
  8. Article
  9. Secrets of DNA-PKcs beyond DNA repair.NPJ precision oncology · 2024
    Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. ALK signaling primes the DNA damage response sensitizing ALK-driven neuroblastoma to therapeutic ATR inhibition.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Sapir Schlam-BabayovThe David and Inez Myers Laboratory of Cancer Genetics, Department of Human Molecular Genetics and Biochemistry, Tel Aviv University School of Medicine, Tel Aviv, Israel.ORCID 0000-0003-0705-8080
Ariel BensimonDepartment of Biology, Institute of Molecular Systems Biology, ETH Zurich, Zurich, Switzerland.ORCID 0000-0003-1862-6987
Michal HarelDepartment of Human Molecular Genetics and Biochemistry, Tel Aviv University School of Medicine, Tel Aviv, Israel.ORCID 0000-0002-6384-1523
Tamar GeigerDepartment of Human Molecular Genetics and Biochemistry, Tel Aviv University School of Medicine, Tel Aviv, Israel.ORCID 0000-0002-9526-197X
Ruedi AebersoldDepartment of Biology, Institute of Molecular Systems Biology, ETH Zurich, Zurich, Switzerland.ORCID 0000-0002-9576-3267
Yael ZivThe David and Inez Myers Laboratory of Cancer Genetics, Department of Human Molecular Genetics and Biochemistry, Tel Aviv University School of Medicine, Tel Aviv, Israel.
Yosef ShilohThe David and Inez Myers Laboratory of Cancer Genetics, Department of Human Molecular Genetics and Biochemistry, Tel Aviv University School of Medicine, Tel Aviv, Israel.ORCID 0000-0002-1538-6060
Tel Aviv University · ILETH Zurich · CHUniversity of Zurich · CH

Funding

Dr. Miriam and Sheldon G. Adelson Medical Research Foundation (AMRF) 341/18Israel Cancer Research Fund (ICRF)
6 · The paper itself

Abstract

The DNA damage response (DDR) is a complex signaling network that relies on cascades of protein phosphorylation, which are initiated by three protein kinases of the family of PI3-kinase-related protein kinases (PIKKs): ATM, ATR, and DNA-PK. ATM is missing or inactivated in the genome instability syndrome, ataxia-telangiectasia (A-T). The relative shares of these PIKKs in the response to genotoxic stress and the functional relationships among them are central questions in the genome stability field. We conducted a comprehensive phosphoproteomic analysis in human wild-type and A-T cells treated with the double-strand break-inducing chemical, neocarzinostatin, and validated the results with the targeted proteomic technique, selected reaction monitoring. We also matched our results with 34 published screens for DDR factors, creating a valuable resource for identifying strong candidates for novel DDR players. We uncovered fine-tuned dynamics between the PIKKs following genotoxic stress, such as DNA-PK-dependent attenuation of ATM. In A-T cells, partial compensation for ATM absence was provided by ATR and DNA-PK, with distinct roles and kinetics. The results highlight intricate relationships between these PIKKs in the DDR.

Indexed as

Ataxia Telangiectasia Mutated ProteinsCell LineCell Line, TumorDNA-Binding ProteinsDNA Breaks, Double-StrandedDNA DamageDNA RepairHeLa CellsHumansPhosphatidylinositol 3-KinasesPhosphorylationProteomicsSignal TransductionAtaxia Telangiectasia Mutated ProteinsDNA-Binding ProteinsPhosphatidylinositol 3-Kinasesataxia-telangiectasiaATMDNA damage responsephosphoproteomicsPIKKs

Identifiers

PMID33215756
PMCPMC7809795
OpenAlexW3105238532

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.